BioFactors · 2019 · 10 citations · 19 references
MedicineEndocrinologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlHormone SecretionIon Channel PharmacologyAdvanced Glycation End ProductsAntidiabetic ActivityChannelsNitric OxideNitric Oxide Synthase RegulationTransient Receptor Potential Channel PharmacologyTransient Receptor Potential ChannelsUncoupling Proteins
Enhancing soluble receptor for advanced glycation endproducts (sRAGE) is considered as a potent strategy for diabetes therapy. sRAGE secretion is regulated by calcium and transient receptor potential canonical (TRPC) channels. However, the role of TRPC channels in diabetes remains unknown. 18β-Glycyrrhetinic acid (18β-GA), produced from liquorice, has shown antidiabetic properties. This study was aimed to investigate the effect of 18β-GA on sRAGE secretion via TRPC channels in high glucose (HG)-induced THP-1 cells. HG treatment enhanced TRPC3 and TRPC6 expression and consequently caused reactive oxygen species (ROS) accumulation mediated through p47 nicotinamide-adenine dinucleotide phosphate oxidase and inducible nitric oxide synthase (iNOS) associated with uncoupling protein 2 (UCP2) decline and lower sRAGE secretion. Interestingly, 18β-GA showed the dramatic effects similar to Pyr3 or 2-aminoethyl diphenyl borinate inhibitors and effectively reversed HG-elicited mechanisms including that blocking TRPC3 and TRPC6 protein expressions, suppressing intracellular [Ca2+] concentration, decreasing expressions of ROS, p47s, and iNOS, but increasing UCP2 level and promoting sRAGE secretion. Therefore, 18β-GA provides a potential implication to diabetes mellitus and its complications.
19
Jun Zeng, Yizhao Chen, Rui Ding et al. · Journal of Neuroinflammation · 2017 · 325 citations · Full text
Chung‐Yi Wang, Tzu-Chien Kao, Wen-Hsieh Lo et al. · Journal of Agricultural and Food Chemistry · 2011 · 194 citations